Crossmark

Correction: Harnessing nanomedicine to target NFκB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation

Crossref DOI link: https://doi.org/10.1186/s12964-026-02759-6

Published Online: 2026-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

BharathwajChetty, Bandari https://orcid.org/0000-0002-4147-3993
Aswani, Babu Santha https://orcid.org/0009-0003-2763-5671
Shinde, Shweta S.

Alqahtani, Mohammed S.

Abbas, Mohamed

Sethi, Gautam https://orcid.org/0000-0002-8677-8475
Ma, Zhaowu

Kunnumakkara, Ajaikumar B. https://orcid.org/0000-0001-9121-6816
License Information

Text and Data Mining valid from 2026-02-25

Version of Record valid from 2026-02-25
More Information

Article History

First Online: 25 February 2026